Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
While listening to Nasrat ask yourself, "Does this sound like someone working diligently to reward shareholders?"
Further, ask yourself, "Does this sound like someone who is diligently working to suppress the price of the stock for any number of self-serving reasons?" -Danke
The vast majority of Elite shareholders would be ecstatic were they down only 46.52% on their investment. . . . While folks are speculating as to what Nasrat "sees", one can rest assured he sees himself retiring as CEO when he sees fit regardless of the share price of ELTP stock. That could easily be another 46.52% below the current price. NAZ might say, "If it is possible, I can do it!".
Currently, $120.00 will buy you an OK skateboard, or 4000 shares of ELTP.. . .
If Nasrat is bored with the sluggish pace at his current position, rather than inspire by bringing dynamic innovative thinking into the scheme of things, I think he should audition for 'Bad CEO'.
A frequent off-shoot of "The Nasrat Effect", or what is more commonly known
as "Poverty" , is abject denial on the part of the unfortunate shareholder, as well
as , in particular, notable cases, the development and verbose display of delusions of grandeur.
In the spirit of a "democratic" message board, I think we should have more concise alternatives to
"Nasrat The Great".
Nasrat The Absent
Nasrat The Mysterious
Nasrat The Rich
Nasrat The Shady
Nasrat The Loaf
Nasrat The Stoppable
Nasrat The Scorned
Nasrat The Loser
etc.,etc.. . .
Ah, "The good old days", when shareholders were in disbelief and anger over a share-price of $0.10. . .
. . . And rightly so, given the ridiculous fist-pumping speeches of Nasrat.
Someone said Elite shareholders are, "Stuck between a rock and a hard-place." . . .
Both of these alternatives imply a sense of solidity, of something approaching
"permanence". In a world where small pharmaceutical companies mismanaged
due to greed and complacency vanish as frequently as they decline into $0.0001
oblivion, I get the "between-ness". Shame on Nasrat.
Oh please if you would deign to tell us more. . . and put away the thesaurus.
'10,000 Jokes, Toasts, and Roasts' should serve just fine here.
Surely for ELTP to reward longstanding shareholders some attention should be paid to both what is said and how things are said.
Otherwise the market will react to press releases from ELTP as non-events at best. At least their press release is relatively coherent.. . .
"He was the VERY last one to predict (predicted today) and he WON!!!!!!!!!!"
Nasrat should probably point that out.
Yeah. . .anythings possible, but most likely "same old same old", i.e. Nasrat wants to run the company as his hobby and he doesn't care if the share price hits $0.0001 before his retirement.
"Take the good with the bad.". . . ". . . glass half-full", etc.
ELTP $0.0345 "Seeing is believing."
Why bother quoting Nasrat, whose emphatic assurances have proven thoroughly unreliable again, and again, and again?. . . "Not believing is seeing!".
Nasrat should be part of the solution rather than part of the problem. . .
Given the current state of global affairs, I think Nasrat should do all that he can to ameliorate the current energy crisis. Were he to divest himself of a portion of the coal reserves he has built up over successive Christmases his impact could be significant. . . . So, Doc, How much coal can we fit in the Delorean?
"When conducting an analysis, it is important to look not only at the known but, upon analysis, the more obviousness of the unknown; which is often the basis for thoughtful analysis and assessment. With that as my grounding..."
- Perhaps this is relevant to a "fall from grace" that found Nasrat Hakim as CEO of Elite Pharmaceuticals.
NOPE! The reply to my post, "BS and lies." belongs here.
"Leg-pulling" on a financial message-board is bad enough.
. . . What to make of delusion on a financial message-board as it
grows as if in a Petri-dish?. . .
When you are singing Nasrat's praises on August 31, 2032 when the share price is all of 5 cents after a reverse-split, you might "re-think" and recognize that while "There are many paths you can go by.", rather than attempting to solve problems facing a company and it's shareholders, Nasrat has chosen to attempt to solve problems facing a CEO.
The history of Elite Pharmaceuticals has been a history of loss since Nasrat Hakim became CEO. He has done little, if anything right. Sound, intelligent reasons existed for inaction or contrary action on his part in virtually every instance of his acting. . . . Greedy, lazy, stupid reasons exist explaining why Elite can now be considered among the all too many poorly run small pharmaceutical companies that are considered malingering financial sink-holes on the OTCBB exchange.
It has been said, "The market is firstly a voting-machine, and subsequently, a weighing-machine." -Thus, Behold Shareholders! Nasrat's Flea-Circus gives you $0.038/ share!
In the most recent conference call Senor Nasrat Hakim showed a paradoxically both shameful and shameless lack of effort which characterizes most if not all of what he has done at Elite Pharmaceuticals. Don NAZ provided the same answers to the same questions that were brought up at the last conference-call. What was said, and the manner in which it was said clearly point to a situation wherein a presenter, having given little or no thought to the important issues raised by shareholder's questions, makes a feeble attempt at meeting his obligations with a "cut-and-paste", at times verbatim, repeat of the inadequate answers he previously provided to 'cherry-picked" questions.
. . . As those blasted conference-calls are always so much damned work, no doubt after such an undignified presentation, Nasrat and his entourage handsomely rewarded themselves for a job well-done as is only right for such dedicated, hard-working, and deserving management.
"everybody knows everybody in New Jersey." . . . That is why my man NAZ can't get favorable terms on any sort of loan.
What makes Nasrat stand-out as a CEO is the number of outstanding shares!
. . . Nasrat needs a credible "mission-statement". . . . Has Nasrat himself ever actually believed in working towards "Dollar-land"?. . . -Except perhaps as a story meant to entice those he considers gullible and foolhardy (current and potential shareholders) into purchasing shares? . . . It would have sufficed to simply ask, "Has Nasrat himself ever actually believed in working?" Period.
An objective reading of the latest conference call transcript would appear to suggest that Nasrat is intentionally making statements that could have a negative impact upon the stock price. . . . Check for yourself. While, yes, it can be said that Nasrat is indeed a moron, given his obligations to shareholders, many of the things he says, and the context in which he says them exceed everyday, run-of-the-mill stupidity. Prior conference-call transcripts show an overabundance of such statements as well.
Rather than be depressed or delusional, why don't you adopt a realistic stance regarding Nazrat, i.e. the scumbag who took your money and who is surely going to misspend whatever he has left of it.
For NAZ to merit the designation, "Super-villian", he does not have to do a thing. He can simply continue to not do all the things he is not doing. Thus, he has made the perhaps enviable situation for himself whereby for him to be considered a, "Super-Hero", all he has to do is get off his lazy-ass and do a few things even he might get his head around.
Most-likely, NAZ would simply dismiss all this as "name-calling" saying," Heck, I don't care in the slightest what "designation" I merit. -Most everyone has referred to me in ugly, derogatory terms for as long as I can remember anyway.".
You want to have a regular turnover at the CFO position as they are the one's who make all of those "fantastic" "forward-looking statements",-As when we were assured the "rock-bottom" share-price was $0.40 many years ago.
What a shame! What a sham! What a scumbag CEO!
When did shareholders become the enemy?. . . When it was decided
Nasrat would play CEO.
Your patience will be rewarded. . .
. . . with condescension and derisive laughter from Naz and the whole Northvale
Pharma Posse!
If 10 people contribute 150 shares each, we can buy Nasrat a wheelbarrow for his shares. -For 300 shares each we can get him a pallet-truck!. . . Unfortunately, Nasrat's reach exceeds his grasp, which happens all too frequently with ill-bred children. This has created a very unfortunate situation for shareholders as all those shares cause exactly what we are witnessing with the share -price.
Nasrat is not without skill, it is just that his skill-set is solely intended to move money from shareholder's pockets to his.. . . Thus, the need for the wheelbarrow or similar. Perhaps someone could speak with his mother.
"the current price is immaterial." - A mantra from the camp of "The Hopeful's".. . . (Stay Tuned)
Yep! $0.04 is pretty much "immaterial".
. . . "Where'd it all go Honey?!"
Or that guy with the discounted cash flow (DCF) analysis?
"Please stop the nonsense... "
If there ever was a case of "The pot calling the kettle black". . .
An expression of serious misgivings regarding the future of ELTP is hardly nonsensical. Alluding to the current state of affairs I might sound a bit "nonsensical" stating, "Elite Pharmaceuticals! Sell the Rumor! Sell the News!"
. . . Sometimes simile and metaphor can be used to express extreme situations so as to avoid appearing verbose and bombastic. Certainly, the situation with ELTP is somewhat extreme, what with LCI as a partner amongst numerous other things numbering well over a billion.
It's probably happened to everyone.. . . Someone's behavior or lack thereof makes you justifiably angry and you say something you regret, not because said person isn't worthy of the utmost contempt, but simply because what you said was just not very well considered and a departure from your best self.. . .
Some of us are no doubt really trying here NAZ. If this is what you call "stewardship", you should actually consider early retirement rather than mingling the idea with your business approach.
The first thing I would say to NAZ were I blessed with the great honor of making his acquaintance would most likely be, "Feet off the desk, NAZ! (2X)
" I see the negatives and the positives" Let us hope my man NAZ of North Jersey shares your keen foresight as he may be called to "tell the Truth, the whole Truth, and nothing but the Truth" in the not so distant future.
You might be able to leave your great-great-grandchildren a potential fortune in ELTP stock. And, as the price may very well remain below $0.04 for their lifetimes, you will have started a family tradition.
"I have a total of 2,503,000 shares with an average buy in price of 8.9 cents/share.". . . Glad you got that out of the way.. . . Who knows, your confidence in ELTP could prove contagious!
Snupchime?
I should have said, "when the market agrees with me" for manifold reasons. . . . Let's consider the statement: "The stock price will go up when Nasrat wants it to go up.". Such might be indicative of a corporate culture leading to a stock price that does not go up. . . such as we are, and have been seeing for some time now.. . . NAZ! C'mon NAZ! Gotta get on up! Gotta stay on the scene! You know ka-razor!
When the market speaks for me, I guess that's good.
-Been here forever, since Jerry and Phentermine. Loved the dog on the CC. That would be the one in which the prior CEO called the FDA "son's of bitches".. . . Nasrat was presented with no easy row to hoe, but he made it pretty easy for himself at the expense of shareholders. -No criminal malfeasance, but given what he was handed, he should have more carefully considered getting Sequestox to market. The CRL has hamstrung the company. Certainly Sequestox could have made it to market at the time of it's rejection. And it would have saved lives. Is that on the FDA, or Nasrat's ineptitude?
. . . How many shareholders of pharmaceutical companies ask daily, "Is that on the FDA, or the CEO's incompetence?" We are not alone.